Q1 FY27 saw resilient performance with strong Indian margins and robust downstream growth, despite global supply chain and regulatory challenges. Major capex was approved for Neelachal Ispat, while European operations faced regulatory and operational headwinds.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.